scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1084132533 |
P356 | DOI | 10.1038/SREP44653 |
P932 | PMC publication ID | 5356346 |
P698 | PubMed publication ID | 28304380 |
P50 | author | Michael S. Torbenson | Q106615136 |
Rondell P Graham | Q48088845 | ||
P2093 | author name string | Praveen Sethupathy | |
Lola M Reid | |||
Tsunekazu Oikawa | |||
Mengjie Chen | |||
Eliane Wauthier | |||
Grace O Silva | |||
Eva C M Vitucci | |||
Kevin G Greene | |||
Wendy A Pitman | |||
Timothy A Dinh | |||
P2860 | cites work | Differential expression analysis for sequence count data | Q21184103 |
Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII. | Q51785175 | ||
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma | Q54345071 | ||
Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features | Q72855415 | ||
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis | Q81791423 | ||
Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma | Q82971565 | ||
The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma | Q84073513 | ||
Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma | Q84161346 | ||
C6orf176: a novel possible regulator of cAMP-mediated gene expression | Q24298149 | ||
Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins | Q24308079 | ||
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers | Q24651144 | ||
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma | Q27852915 | ||
Unique genomic profile of fibrolamellar hepatocellular carcinoma | Q27853116 | ||
DNAJB1-PRKACA is specific for fibrolamellar carcinoma. | Q27853135 | ||
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 | ||
p21-Activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration | Q28296152 | ||
Neuroendocrine-specific expression of the human prohormone convertase 1 gene. Hormonal regulation of transcription through distinct cAMP response elements | Q28304253 | ||
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome | Q29547458 | ||
Circular binary segmentation for the analysis of array-based DNA copy number data | Q29615406 | ||
Hepatocellular carcinoma | Q29615765 | ||
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer | Q30488162 | ||
Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data | Q30657766 | ||
Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 | ||
Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database | Q33695465 | ||
Fibrolamellar carcinomas are positive for CD68 | Q33757399 | ||
MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. | Q34077389 | ||
MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. | Q34189334 | ||
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients. | Q34458870 | ||
Outcome of patients with fibrolamellar hepatocellular carcinoma. | Q34494031 | ||
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool | Q34668270 | ||
Genomic analysis of fibrolamellar hepatocellular carcinoma | Q34673400 | ||
The functional role of long non-coding RNA in human carcinomas | Q34995156 | ||
Structural insights into mis-regulation of protein kinase A in human tumors. | Q35062811 | ||
High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma | Q35114504 | ||
RNA-mediated epigenetic regulation of gene expression | Q35223649 | ||
The epidemiology of cholangiocarcinoma | Q35802314 | ||
TCGA2STAT: simple TCGA data access for integrated statistical analysis in R. | Q35841457 | ||
Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver | Q35922081 | ||
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells | Q36145871 | ||
Transcriptomic characterization of fibrolamellar hepatocellular carcinoma | Q36268536 | ||
Systematic pan-cancer analysis of tumour purity | Q36350773 | ||
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma | Q36642291 | ||
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. | Q36649171 | ||
Non-coding RNA LINC00473 mediates decidualization of human endometrial stromal cells in response to cAMP signaling | Q36656860 | ||
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. | Q36951807 | ||
KEA: kinase enrichment analysis | Q37109842 | ||
Fibrolamellar carcinoma: 2012 update | Q37288706 | ||
Anterior gradient-2 is overexpressed by fibrolamellar carcinomas | Q37352343 | ||
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma | Q37408965 | ||
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma | Q37553809 | ||
Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors | Q37846146 | ||
Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 | ||
Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. | Q38307214 | ||
Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma. | Q38416844 | ||
Unique features of long non-coding RNA biogenesis and function | Q38668939 | ||
Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors. | Q39450874 | ||
Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway | Q39708680 | ||
Molecular characteristics of fibrolamellar hepatocellular carcinoma. | Q40055042 | ||
FGFR1 and FGFR2 in fibrolamellar carcinoma | Q40640497 | ||
Inhibition of cyclic AMP-dependent induction of ornithine aminotransferase by simple carbohydrates in cultured hepatocytes | Q42200177 | ||
New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism | Q44226601 | ||
Transcriptional analysis of the human ornithine aminotransferase promoter | Q44314585 | ||
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. | Q46688979 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | DESeq2 | Q113018293 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | The Cancer Genome Atlas | Q3979425 |
non-coding RNA | Q427087 | ||
RNA analysis | Q95588220 | ||
P304 | page(s) | 44653 | |
P577 | publication date | 2017-03-17 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma | |
P478 | volume | 7 |
Q64280822 | An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma |
Q47635386 | CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma. |
Q48201057 | CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells |
Q42367909 | Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics |
Q47377422 | DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma. |
Q89898304 | DnaJ-PKAc fusion induces liver inflammation in a zebrafish model of Fibrolamellar Carcinoma |
Q54117733 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers |
Q47312923 | Fibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion. |
Q52689575 | Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms |
Q64882814 | Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review. |
Q58708035 | LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer |
Q41670848 | Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells |
Q47150980 | Long non‑coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT‑PCR and meta‑analysis of 393 cases |
Q92366663 | Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling |
Q64230086 | MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma |
Q97551598 | Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver |
Q52657106 | Non coding RNA analysis in fibrolamellar hepatocellular carcinoma |
Q92816722 | Phytochemicals as Modulators of Long Non-Coding RNAs and Inhibitors of Cancer-Related Carbonic Anhydrases |
Q92618325 | Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma |
Q61805289 | Road map for fibrolamellar carcinoma: progress and goals of a diversified approach |
Q55472607 | TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer. |
Search more.